Olema Pharmaceuticals所有资讯

Olema Pharmaceuticals | ARS：年度报告

04/26 17:21 (美东)

Olema Pharmaceuticals | DEFA14A：其他

04/26 17:15 (美东)

Olema Pharmaceuticals | DEF 14A：股东委托书决议

04/26 17:10 (美东)

Olema Pharmaceuticals | 4：持股变动声明-董事 Harmon Cyrus

03/29 17:03 (美东)

Olema Pharmaceuticals | 144：拟议出售证券

03/28 11:09 (美东)

Olema Pharmaceuticals | SC 13G：超过5%持股股东披露文件-Deep Track Capital, LP(5.44%),Deep Track Biotechnology Master Fund, Ltd.(5.44%)等

03/22 16:36 (美东)

Olema Pharmaceuticals | 4：持股变动声明-高管 Zojwalla Naseem

03/20 17:33 (美东)

Olema Pharmaceuticals | S-8：员工福利计划证券登记

03/11 16:34 (美东)

Olema Pharmaceuticals | 10-K：年度报表

03/11 16:23 (美东)

Olema Pharmaceuticals | 8-K：Olema Oncology公布2023年第四季度和全年财务业绩，并提供公司最新情况

03/11 16:09 (美东)

Olema Pharmaceuticals | 4：持股变动声明-董事 RAPPAPORT ANDREW

03/06 17:40 (美东)

Olema Pharmaceuticals | 4：持股变动声明-董事 Harmon Cyrus

03/04 17:45 (美东)

Olema Pharmaceuticals | 144：拟议出售证券

02/29 14:30 (美东)

Olema Pharmaceuticals | SC 13G/A：超过5%持股股东披露文件(修正)-Paradigm BioCapital Advisors LP(14.3%),Paradigm BioCapital Advisors GP LLC(14.3%)等

02/14 17:53 (美东)

Olema Pharmaceuticals | SC 13G/A：超过5%持股股东披露文件(修正)-Cormorant Asset Management, LP(4.49%),Bihua Chen(4.49%)等

02/14 15:13 (美东)

Olema Pharmaceuticals | SC 13G/A：超过5%持股股东披露文件(修正)-Kynam Capital Management, LP(0%),Kynam Capital Management GP, LLC(0%)等

02/14 12:59 (美东)

Olema Pharmaceuticals | 424B3：募资说明书

02/12 17:22 (美东)

Olema Pharmaceuticals | SC 13G/A：超过5%持股股东披露文件(修正)-Janus Henderson Group plc(1.3%)

02/12 12:25 (美东)

Olema Pharmaceuticals | EFFECT：其他

02/12 07:08 (美东)

Olema Pharmaceuticals | CORRESP：信函

02/07 22:16 (美东)